Showing results (691-700 of 712) with videos related to
Sort By:
Pageof 72
Cancer & Metabolism|December 10, 2022
Functional noninvasive detection of glycolytic pancreatic ductal adenocarcinomaIrina Heid, Corinna Münch, Sinan Karakaya, et al.International Journal of Molecular Sciences|May 13, 2023
Genetic Profiling of Sodium Channels in Diabetic Painful and Painless and Idiopathic Painful and Painless NeuropathiesRowida Almomani, Maurice Sopacua, Margherita Marchi, et al.Pharmaceutics|August 28, 2025
Extemporaneous Compounding, Pharmacy Preparations and Related Product Care in the NetherlandsHerman J Woerdenbag, Boy van Basten, Christien Oussoren, et al.American Journal of Human Genetics|May 21, 2011
Mutations in ZBTB24 are associated with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2Jessica C de Greef, Jun Wang, Judit Balog, et al.Inflammatory Bowel Diseases|February 13, 2014
Effect of aging on healthcare costs of inflammatory bowel disease: a glimpse into the futureMike van der Have, Marie-Josée J Mangen, Mirthe E van der Valk, et al.Annals of Clinical and Translational Neurology|March 27, 2019
Leigh syndrome caused by mutations in <i>MTFMT</i> is associated with a better prognosisHannah Hayhurst, Irenaeus F M de Coo, Dorota Piekutowska-Abramczuk, et al.Brain : a Journal of Neurology|March 7, 2008
REEP1 mutation spectrum and genotype/phenotype correlation in hereditary spastic paraplegia type 31Christian Beetz, Rebecca Schüle, Tine Deconinck, et al.Pain|March 23, 2022
Features and methods to discriminate between mechanism-based categories of pain experienced in the musculoskeletal system: a Delphi expert consensus studyMuath A Shraim, Kathleen A Sluka, Michele Sterling, et al.BMC Neurology|August 13, 2021
Natural history, outcome measures and trial readiness in LAMA2-related muscular dystrophy and SELENON-related myopathy in children and adults: protocol of the LAST STRONG studyKarlijn Bouman, Jan T Groothuis, Jonne Doorduin, et al.European Heart Journal|October 27, 2015
Hypertrophic remodelling in cardiac regulatory myosin light chain (MYL2) founder mutation carriersGodelieve R F Claes, Florence H J van Tienen, Patrick Lindsey, et al.Pageof 72